Bryn Mawr Capital Management’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-2,661
Closed -$328K 451
2025
Q3
$328K Sell
2,661
-160
-6% -$19.9K 0.02% 334
2025
Q2
$339K Buy
2,821
+114
+4% +$15.2K 0.02% 327
2025
Q1
$399K Sell
2,707
-4
-0.1% -$611 0.02% 286
2024
Q4
$440K Buy
2,711
+185
+7% +$30.3K 0.02% 291
2024
Q3
$411K Buy
2,526
+15
+0.6% +$2.22K 0.02% 302
2024
Q2
$333K Sell
2,511
-30,950
-92% -$4.3M 0.02% 322
2024
Q1
$691K Buy
33,461
+29,006
+651% +$4.33M 0.04% 255
2023
Q4
$635K Buy
4,455
+718
+19% +$95.7K 0.04% 260
2023
Q3
$490K Buy
+3,737
New +$568K 0.03% 275

Other funds holding CLX

Bryn Mawr Capital Management's CLX Position: Q4 2025 in Review

Bryn Mawr Capital Management sold out of Clorox (CLX) in Q4 2025, closing a stake of 2,661 shares — an estimated $328K sold.

Bryn Mawr Capital Management first reported a position in CLX in Q3 2023 and held it in 9 quarters. The position peaked at $691K in Q1 2024. 1,049 funds tracked by Wall St. Rank hold CLX as of Q4 2025.

  • Bryn Mawr Capital Management reported no remaining Clorox position as of Q4 2025 after selling out during the quarter.
  • Bryn Mawr Capital Management sold 2,661 Clorox shares in Q4 2025, an estimated $328K.
  • Bryn Mawr Capital Management first reported a position in Clorox in Q3 2023 and held it in 9 quarters.
  • Bryn Mawr Capital Management's Clorox position peaked at $691K in Q1 2024.
  • 1,049 funds tracked by Wall St. Rank held Clorox as of Q4 2025.

Based on Bryn Mawr Capital Management's 13F filing for Q4 2025, filed 4 Feb 2026.